Home
Introduction
GEFOS stands for the GEnetic Factors for OSteoporosis Consortium. It is a large international collaboration involving various prominent research groups.
Osteoporosis is a common age-related complex disease with a strong genetic component. Osteoporotic
fractures account for considerable disease burden and costs.
The genes responsible, however, are poorly defined. It is by now generally assumed that - like for
many other complex diseases such as diabetes and cardiovascular disease - many gene variants are
responsible but each with subtle effect.
In a previous EU FP5 funded project, named GENOMOS, we have improved on this situation by bringing
together several of Europe's largest collections of osteoporosic study populations with DNA available,
and analysing the most commonly studied.
With the GEFOS project we here propose to capitalize on the success of GENOMOS by using the most advanced
gene discovery tools that have become recently available, i.e., Genome Wide Association (GWA) analysis
with high density SNP arrays, to identify common risk gene variants for osteoporosis.
GEFOS is a European Union Seventh Framework Package funded project, registered under grant agreement number: FP7-HEALTH- F2-2008-201865-GEFOS
News
Place: To be informed (near the ECTS Conference Center)
Date: May 7th, from 12:00 - 2:00 PM.
Lunch will be served.
The American Society for Bone and Mineral Research (ASBMR): October 15 - 19, 2010
Place: Queens Quay room, Westin Harbour Castle, Toronto, ONTARIO (near the ASBMR Conference Center)
Date: October 19th, from 1:00 - 5:00 PM.
Address: One Harbour Square * Toronto, ON * CANADA * M5J 1A6
Lunch will be served.
Link to Endocrine Reviews
Link to Ann Int Medicine
Link to Nature Genetics
Download press release


